Drug interactions
Ado-trastuzumab + Palifermin
Severity: Moderate
Ado-trastuzumab and Palifermin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Palifermin stimulates epithelial cell growth and, when given close to cytotoxic chemotherapy, was associated with worse oral mucositis in labeling.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Ado-trastuzumab and Palifermin interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Ado-trastuzumab
Other interactions of Palifermin
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.